In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alpha Therapeutic Corp.

Division of Mitsubishi Chemical Holdings Corp.

Latest From Alpha Therapeutic Corp.

Deal Statistics Quarterly, Q3 2003

In Vivo presents another installment of our quarterly reivew of dealmaking--in this case July-September 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.

BioPharmaceutical Medical Device

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.

Dealmaking (09/02)

Summarizing the month in European dealmaking.

Xencor Inc.

Start-up company Xencor is developing protein-based pharmaceuticals using computational technology.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mitsubishi Chemical Holdings Corp.
  • Senior Management
  • Claude Miller, Pres. & CEO
    Joseph A D`Arco, SVP, Bus. Dev.
    Pete DeHart, SVP, Worldwide Sales & Mktg.
    William S Craig, PhD, VP, R&D
  • Contact Info
  • Alpha Therapeutic Corp.
    Phone: (323) 225-2221
    2410 Lillyvale Ave.
    Los Angeles, CA 90032